Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
monoclonal antibody
|
| gptkbp:clinicalTrials |
Phase 1
|
| gptkbp:developedBy |
gptkb:TetraLogic_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
TTX-030
|
| gptkbp:isPortrayedBy |
2015
|
| gptkbp:mandates |
solid tumors
|
| gptkbp:route |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
PD-1
|
| gptkbp:triggerType |
immune checkpoint inhibition
|
| gptkbp:usedFor |
cancer treatment
|